로딩 중…
지수 로딩 중…
Omeros Corporation
OMER· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$10.28+6.64%
2026-06-18
Price Chart
Omeros Corporation+219.25%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $744M |
| Revenue | $10M |
| Net Income | $86M |
| Total Assets | $286M |
| Net Assets | $86M |
| Value | |
| P/E | 8.63x |
| P/B | 8.68x |
| P/S | 75.21x |
| FCF Yield | -12.74% |
| Profitability | |
| ROE | 100.57% |
| ROA | 30.11% |
| Op. Margin | -1063.86% |
| Financial Health | |
| Debt Ratio | 407.90% |
| Total Debt | $311M |
| FCF | $-95M |
| Cash | $2M |
| Current Ratio | 3.03x |
| Performance | |
| 1Y Return | 219.25% |
| 1M Return | -14.12% |
| From 52W High | -41.76% |
| 1Y MDD | -67.58% |
| Trading | |
| Volume | 2,569,783 shares |
| Trading Value | $26M |
| Per Share | |
| EPS | $-1.36 |